Turner syndrome is a genetic condition that affects roughly 1 in every 2,000 to 4,000 female live births worldwide. It occurs when one of the two X chromosomes is missing, incomplete, or structurally altered. The condition affects growth, sexual development, heart health, and fertility, though the severity varies widely from person to person.
What Causes Turner Syndrome
Every cell in your body normally carries 46 chromosomes, including two sex chromosomes. Females typically have two X chromosomes (XX). In Turner syndrome, one of those X chromosomes is completely or partially absent. This isn’t caused by anything a parent did or didn’t do. It results from a random error in how chromosomes divide, either in the sperm, the egg, or during early cell division after conception.
There are a few different patterns. In the most straightforward form, called monosomy, every cell in the body has just one X chromosome instead of two. This accounts for about half of cases. In another pattern called mosaicism, only some cells are missing the second X chromosome while others are normal. People with mosaicism often have milder features because a portion of their cells function with the typical two X chromosomes. In a third pattern, both X chromosomes are present, but one has structural damage: a missing section, a rearrangement, or other alteration.
How It’s Diagnosed
Turner syndrome can be detected before birth, at birth, or sometimes not until the teenage years when puberty doesn’t progress as expected. Before birth, certain ultrasound findings can raise suspicion, including excess fluid at the back of the neck (increased nuchal translucency), cystic hygroma, heart or kidney abnormalities, and shorter-than-expected limb bones. Cell-free DNA screening, a blood test offered to pregnant women, can also flag a possible case, but it has a relatively high rate of false positives for Turner syndrome compared to other chromosomal conditions. Only about 26% of positive screens for Turner syndrome turn out to be confirmed cases.
The definitive diagnosis requires a karyotype, a lab test that maps out all 46 chromosomes from a blood or tissue sample. Before birth, this means amniocentesis or chorionic villus sampling. After birth, a simple blood draw is enough. No screening result alone confirms the diagnosis.
Many girls are identified in childhood because of noticeably slow growth, or in adolescence when puberty doesn’t start on its own. In milder mosaic cases, some women aren’t diagnosed until they seek help for infertility in adulthood.
Physical Features and Early Signs
The two hallmark features present in nearly all cases are short stature and ovarian insufficiency. Beyond those, Turner syndrome can produce a wide range of physical characteristics, though no single person has all of them.
At birth, some signs are visible right away: swelling of the hands and feet (lymphedema), a wide or webbed neck, low-set ears, a broad chest with widely spaced nipples, and a low hairline at the back of the head. Newborns with Turner syndrome are often slightly shorter than average. In childhood, growth continues to lag behind peers, and the expected growth spurts simply don’t happen on schedule. Without treatment, the average adult height is about 4 feet 8 inches, though this varies.
Growth Hormone Therapy
Growth hormone injections are the standard approach to improving adult height. Guidelines from the Cincinnati International Turner Syndrome Meeting recommend starting treatment early, ideally between ages 4 and 6, if a child shows evidence of growth failure or has a high likelihood of short stature based on parental height. Treatment should begin before ages 12 to 13 to get the most benefit.
Growth hormone is given as a daily injection, and treatment typically continues for several years. The goal isn’t to reach a specific height but to close the gap between where a child’s growth is tracking and where it would be without the condition. Starting earlier generally produces better results because there are more years of growth potential remaining.
Puberty and Reproductive Health
About 95% of girls with Turner syndrome develop ovarian failure over time. The ovaries either don’t develop fully or lose their eggs much earlier than usual. This means most girls won’t enter puberty on their own, menstrual periods won’t start, and natural conception is unlikely. Only about 2% of women with Turner syndrome become pregnant spontaneously.
Estrogen replacement therapy is used to initiate and sustain puberty. Treatment typically begins around age 11 to 12, with the dose gradually increased over two to three years to mimic the natural pace of development. Starting with a low dose is important to avoid cutting short any remaining growth potential from growth hormone therapy. Beyond triggering breast development and other pubertal changes, estrogen replacement plays a critical role in long-term bone health. Delaying it too long can lead to weaker bones and underdevelopment of the uterus, which matters if the person later pursues pregnancy through egg donation or assisted reproduction.
Most women with Turner syndrome will need hormone replacement therapy well into adulthood, essentially until the age when menopause would naturally occur.
Heart and Cardiovascular Risks
Heart problems are the most serious medical concern in Turner syndrome. Roughly one third of patients are born with a structural heart defect. The two most common are a bicuspid aortic valve, found in about 16% of patients (the valve between the heart and the body’s main artery has two flaps instead of three), and coarctation of the aorta, a narrowing of the main artery leaving the heart, found in about 11%.
Even without a congenital defect, the aorta deserves ongoing monitoring. Aortic dissection, a tear in the wall of the aorta, occurs at a much higher rate in Turner syndrome than in the general population. In one long-term study of 156 patients, three deaths were attributed to aortic dissection, a number far exceeding what would be expected. Two of those patients had no prior known heart disease. This is why regular cardiac imaging is a lifelong recommendation.
Other Health Conditions to Watch For
Turner syndrome raises the risk of several other conditions, particularly those involving the immune system. Thyroid problems are common. Autoimmune hypothyroidism, where the immune system attacks the thyroid gland, occurs at an annual rate of about 3.2% in women with Turner syndrome, considerably higher than in the general female population. Regular thyroid screening with a simple blood test is part of routine care.
Kidney abnormalities are present in a significant number of cases, though many are mild and don’t cause symptoms. Hearing loss, particularly in middle age, is more common than average. Learning differences can occur too. Most girls with Turner syndrome have normal intelligence, but many experience specific difficulties with spatial reasoning, math, or social cue interpretation, even when verbal skills are strong.
Life Expectancy and Long-Term Outlook
Turner syndrome does affect life expectancy, but the degree depends heavily on whether heart defects are present. A prospective study following patients over an average of 17 years found that life expectancy was reduced by roughly 13 years when measured from age 1. Among the 156 patients in the study, 15 died during follow-up, compared to an expected 3.6 deaths in the general population. Five of those deaths occurred in the 16 patients who had congenital heart defects.
When patients with congenital heart disease were removed from the analysis, the death rate from circulatory problems was no longer significantly elevated, though it remained about three times higher than expected overall from a broad spectrum of causes. This underscores how much of the risk is concentrated in cardiovascular health, and why proactive heart monitoring and treatment can meaningfully change the picture.
With modern care, including growth hormone therapy, estrogen replacement, cardiac surveillance, and screening for associated conditions, many women with Turner syndrome lead full, independent lives. The condition requires long-term management rather than a single course of treatment, but the tools available today are substantially better than those of even a generation ago.